{
  "ticker": "PMC",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02978197",
  "id": "02978197",
  "pages": 3,
  "price_sensitive": false,
  "date": "20250807",
  "time": "1751",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250807/pdf/06mnbcrpwrc83n.pdf",
  "summary": "- **NTA Update (31 July 2025):**  \n  - **Pre-tax NTA:** $1.5735 per share  \n  - **Post-tax NTA:** $1.5226 per share  \n  - **Share price (as of date):** $1.420 (trading at ~9.7% discount to post-tax NTA).  \n\n- **Portfolio Performance:**  \n  - **Monthly return:** +3.9% (outperforming MSCI AC World Index at +3.2%).  \n  - **Key contributors:** Technology (e.g., Taiwan Semiconductor, Alphabet), Communications (Rogers Communications), Healthcare (Novartis, AstraZeneca), and Financials (UBS, Shinhan Financial).  \n  - **Shorts:** Detracted <0.5% from returns.  \n\n- **Valuation Metrics vs. Benchmark (MSCI AC World Index):**  \n  - **Earnings yield:** 8.1% (vs. 5.3% for benchmark).  \n  - **P/E ratio:** 12.3x (vs. 18.8x).  \n  - **Price-to-book:** 1.7x (vs. 3.3x).  \n\n- **Dividend Yield:**  \n  - **Current gross yield:** 4.23% (fully franked).  \n  - **Maximum franked dividend capacity:** 1.75cps.  \n\n- **Market Commentary:**  \n  - Cautious on US market due to tariff uncertainties and debt levels.  \n  - Portfolio positioned with diversification into Europe, Asia, and value sectors (consumer staples, healthcare, industrials).  \n\n*No capital structure changes or material corporate actions announced.*",
  "usage": {
    "prompt_tokens": 2976,
    "completion_tokens": 361,
    "total_tokens": 3337,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-08-07T07:57:27.479879"
}